Utah pausing Johnson & Johnson COVID-19 vaccine following federal recommendation

SALT LAKE CITY — Utah will temporarily suspend its administration of the Johnson & Johnson COVID-19 vaccine after federal regulators recommended pausing the vaccine to investigate a small number of blood clot issues.
The U.S. Centers for Disease Control and Prevention and Food and Drug Administration said Tuesday that blood clot issues were being investigated in six women who had received the one-dose Johnson & Johnson vaccine several days before reporting the clots.
About 6.8 million doses of the Johnson & Johnson vaccine have been administered in the U.S. so far, according to the CDC, so less than one in a million people have experienced clotting issues with the vaccine.

Related Keywords

Utah ,United States ,Johnson ,Us Centers For Disease ,Utah Department Of Health ,Drug Administration ,Disease Control ,Utah Department ,Rich Saunders ,News ,Traffic ,Leather ,Sports ,Lassifieds ,Cars ,Jobs ,Homes ,Television ,Adio ,Salt Lake ,Ocal ,உட்டா ,ஒன்றுபட்டது மாநிலங்களில் ,ஜான்சன் ,எங்களுக்கு மையங்கள் க்கு நோய் ,உட்டா துறை ஆஃப் ஆரோக்கியம் ,நோய் கட்டுப்பாடு ,உட்டா துறை ,பணக்கார சாண்டர்ஸ் ,செய்தி ,போர்ட்ஸ் ,அரசு ,அபெஸ் ,ஆல்ட் ஏரி ,தா ,